European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
Poland is set to significantly increase the import cap on medical cannabis based on continually expanding demand in what is fast becoming one of Europe’s most exciting markets.
Polish medical cannabis company Hemp&Health (WSE:HMP) signed an agreement to acquire a 5% stake in the Portuguese company Hibisco Discreto, owner of the Voyager Genetics brand.
Cosma S.A., a leader in cannabis-based pharmaceutical advancements, and SOMAÍ Pharmaceuticals, a fully vertically integrated Multi-Country Operator (MCO) in the global medical cannabis markets, are thrilled to announce a strategic partnership that designates Cosma as the Marketing Authorization Holder (MAH) for both Cosma and SOMAÍ’s cutting-edge cannabis-based products.
Italy’s Hemp Industry Hopes the EU Will Save it From Government Bill The Italian hemp industry is mounting a defense against the Meloni government’s escalating efforts to criminalise light cannabis, including CBD products, amid fears that these measures could violate European Union regulations and devastate the sector.
PRESS RELEASE Healthcann – the first Polish hemp biotech company – has launched a crowdfunding.
EARLIER this month Czechia’s drug commissioner Jindřich Vobořil announced his intention to submit draft legislation for an adult-use cannabis market by the end of the year, hoping a fully fledged market could be launched by 2024.
Stephen Murphy is the co-founder + CEO of NOBL – the company behind European Cannabis Week, Cannabis Europa and Prohibition Partners. Together, these brands are driving cannabis knowledge and insight into the European cannabis market. As well, Cannabis Europa is bringing their programming to Toronto on November 5th and New York City on November 7th.